# Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Split Dose PicoPrep

> **NCT01073930** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 608 (actual)

## Conditions studied

- Bowel Preparation

## Interventions

- **DRUG:** PicoPrep
- **DRUG:** HalfLytely
- **DRUG:** bisacodyl

## Key facts

- **NCT ID:** NCT01073930
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 608 (ACTUAL)
- **Last updated:** 2013-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01073930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01073930, "Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Split Dose PicoPrep". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01073930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*